Citation Impact
Citing Papers
Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology [RETIRED]
2007
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Cochrane Database of Systematic Reviews
2003 Standout
Astrocytes: biology and pathology
2009 Standout
Increased Lipophilicity and Subsequent Cell Partitioning Decrease Passive Transcellular Diffusion of Novel, Highly Lipophilic Antioxidants
1999 StandoutNobel
PACKMOL : A package for building initial configurations for molecular dynamics simulations
2009 Standout
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man
1993
Leishmaniasis
2018 Standout
Solar photo-Fenton process on the abatement of antibiotics at a pilot scale: Degradation kinetics, ecotoxicity and phytotoxicity assessment and removal of antibiotic resistant enterococci
2012
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
2002 Standout
Efficacy of antibiotic prophylaxis for prevention of lyme disease
1996
Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 −163C>A polymorphism
2010
In vitro susceptibility of thirtyBorrelia strains from various sources against eight antimicrobial chemotherapeutics
1996
Methods for Predicting Human Drug Metabolism
2006
Molecular dissection of reactive astrogliosis and glial scar formation
2009 Standout
Pharmacokinetics of Fluconazole in the Cerebrospinal Fluid of Children with Hydrocephalus
2005
Solar Fenton and solar TiO2 catalytic treatment of ofloxacin in secondary treated effluents: Evaluation of operational and kinetic parameters
2010
Chronic Lyme Disease: A Review
2008
Activities of various β-lactams and β-lactam/β-lactamase inhibitor combinations against Acinetobacter baumannii and Acinetobacter DNA group 3 strains
2005
Final Report of the Lyme Disease Review Panel of the Infectious Diseases Society of America
2010
Health Risks of Herbal Remedies
1995
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
2014 Standout
Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxonein vitro
2009
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
How Can We Prevent Lyme Disease?
2003
Penetration of Anti-Infective Agents into Pulmonary Epithelial Lining Fluid
2011
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
2011 Standout
In Vitro and In Vivo Evaluations of Cytochrome P450 1A2 Interactions with Duloxetine
2008
In vitro activity of vancomycin and teicoplanin againstStaphylococcus aureus andStaphylococcus epidermidis colonizing catheters
1993
DrugBank: a knowledgebase for drugs, drug actions and drug targets
2007 Standout
Nervous system Lyme disease
1998
Management of meningitis due to antibiotic-resistant Acinetobacter species
2009
Successful treatment of neuroborreliosis with ten day regimens
2002
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
Kill kinetics ofBorrelia burgdorferi and bacterial findings in relation to the treatment of lyme borreliosis
1996
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Pharmacodynamic Interactions of Antibiotics Alone and in Combination
1998
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion
2009
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Pharmacokinetics and Pharmacodynamics of Cephalosporins in Cerebrospinal Fluid
2000
EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis
2009
Acne vulgaris
2011 Standout
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Estimation of steady state antibiotic concentration in cerebrospinal fluid from single-dose kinetics
1996
Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: A review
2013 Standout
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro‐drugs used in the management of ulcerative colitis
2002
Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors
1997
PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTIBIOTICS IN MENINGITIS
1999
Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents — Possible implications for new therapeutic approaches to Lyme disease
2002
Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: A review
2012 Standout
Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges
1994
Cost Effectiveness of Oral as Compared with Intravenous Antibiotic Therapy for Patients with Early Lyme Disease or Lyme Arthritis
1997
Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials
2005
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Combinatorial events of insertion sequences and ICE in Gram-negative bacteria
2011
Successful Oral Doxycycline Treatment of Lyme Disease‐Associated Facial Palsy and Meningitis
1999
Clinical Outcome with Oral Linezolid and Rifampin Following Recurrent Methicillin‐Resistant Staphylococcus aureus Bacteremia Despite Prolonged Vancomycin Treatment
2004
Lyme borreliosis
2011 Standout
Trends in Alternative Medicine Use in the United States, 1990-1997
1998 Standout
Pharmacokinetics of moxifloxacin in non-inflamed cerebrospinal fluid of humans: implication for a bactericidal effect
2008
Amyotrophic Lateral Sclerosis
2001 Standout
Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis
1997
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis
2009
A proposal for the reliable culture ofBorrelia burgdorferi from patients with chronic lyme disease, even from those previously aggressively treated
1998
Erythromycin oxidation and ERY-resistant Escherichia coli inactivation in urban wastewater by sulfate radical-based oxidation process under UV-C irradiation
2015
Cerebrospinal Fluid Penetration of Levofloxacin in Patients with Spontaneous Acute Bacterial Meningitis
2001
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Ventilator-associated Pneumonia
2002 Standout
beta-Lactamases in laboratory and clinical resistance
1995
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Antimicrobial Activities of Mefloquine and a Series of Related Compounds
2000
Mobile Genetic Elements Associated with Antimicrobial Resistance
2018 Standout
Gut Microbiota in Health and Disease
2010 Standout
In Vitro Susceptibility Testing ofBorrelia burgdorferiSensu Lato Isolates Cultured from Patients with Erythema Migrans before and after Antimicrobial Chemotherapy
2005
pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures
2015 Standout
Sulfated and carboxymethylated cyclodextrins and their lanthanide complexes as chiral NMR discriminating agents
2003
Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease
1997
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
In Vitro Activities of the β-Lactamase Inhibitors Clavulanic Acid, Sulbactam, and Tazobactam Alone or in Combination with β-Lactams against Epidemiologically Characterized Multidrug-Resistant Acinetobacter baumannii Strains
2004
A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy
2007
Antibiotics for community-acquired pneumonia in adult outpatients
2014
Antibiotic Pharmacodynamics in Cerebrospinal Fluid
1998
Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease)
1996
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
AmpC β-Lactamases
2009 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Invasion of the Central Nervous System by Borrelia burgdorferi in Acute Disseminated Infection
1992
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Synthesis and biological properties of tensyuic acids B, C, and E, and investigation of the optical purity of natural tensyuic acid B
2008 StandoutNobel
Generation of sulfate radical through heterogeneous catalysis for organic contaminants removal: Current development, challenges and prospects
2016 Standout
PEGylation Does Not Significantly Change the Initial Intravenous or Subcutaneous Pharmacokinetics or Lymphatic Exposure of Trastuzumab in Rats but Increases Plasma Clearance after Subcutaneous Administration
2015
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination
2007
Studies on Human Pharmaceuticals in Jordanian Wastewater Samples
2014
Three Decades of β-Lactamase Inhibitors
2010 Standout
Comparison of Cyclodextrin‐Dipeptide Inclusion Complexes in the Absence and Presence of Urea by Means of Capillary Electrophoresis, Nuclear Magnetic Resonance and Molecular Modeling
2007
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Follow-up of Patients Treated with Oral Doxycycline for Lyme neuroborreliosis
2001
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis
2010
Clavulanate Induces Expression of the Pseudomonas aeruginosa AmpC Cephalosporinase at Physiologically Relevant Concentrations and Antagonizes the Antibacterial Activity of Ticarcillin
1999
Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis
2005
Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis
1995
Clinical Correlation of the CLSI Susceptibility Breakpoint for Piperacillin- Tazobactam against Extended-Spectrum-β-Lactamase-Producing Escherichia coli and Klebsiella Species
2006
Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis
1996
How to optimize antibiotic pharmacokinetic/pharmacodynamics for Gram-negative infections in critically ill patients
2018
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing
2020 Standout
Optimal Dosing of Miltefosine in Children and Adults with Visceral Leishmaniasis
2012
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
2001 Standout
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Disposition and Elimination of Meropenem in Cerebrospinal Fluid of Hydrocephalic Patients with External Ventriculostomy
1998
Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro
2004
Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.
1993
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus
1990
Works of F. Sörgel being referenced
Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis.
1997
Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with β-lactams and aminoglycosides
1991
Lack of bioequivalence of a generic mefloquine tablet with the standard product
1998
The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam
1993
Development of a new G-CSF product based on biosimilarity assessment
2009
Determination of erythromycin and related substances in commercial samples using liquid chromatography/ion trap mass spectrometry
2006
Pharmacokinetic characteristics of piperacillin/tazobactam
1994
Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2
1999
Liver and gut mucosa acetylation of mesalazine in healthy volunteers
2000
Randomized Comparison of Ceftriaxone and Cefotaxime in Lyme Neuroborreliosis
1991
Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers
1988
Effects of Temafloxacin and Ciprofloxacin on the Pharmacokinetics of Caffeine†
1992
In-vitro activity of fleroxacin against isolates causing complicated urinary tract infections and concentrations in seminal and prostatic fluid and in prostatic adenoma tissue
1988
The Return of Ehrlich’s ‘Therapia magna sterilisans’ and Other Ehrlich Concepts?
2004
Comparative Pharmacokinetics of Teicoplanin and Vancomycin
2000
Study on the chiral recognition of the enantiomers of ephedrine derivatives with neutral and sulfated heptakis(2,3-O-diacetyl)-β-cyclodextrins using capillary electrophoresis, UV, nuclear magnetic resonance spectroscopy and mass spectrometry
2001
Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation
2007
Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges
1993
Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies
1996
Systematic Comparison of the Population Pharmacokinetics and Pharmacodynamics of Piperacillin in Cystic Fibrosis Patients and Healthy Volunteers
2007
Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
1993
Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia
2011
Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid
1993
Comparable Population Pharmacokinetics and Pharmacodynamic Breakpoints of Cefpirome in Cystic Fibrosis Patients and Healthy Volunteers
2011
Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin
1994
Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro
1992
Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery
1992
Blood, Tissue, and Intracellular Concentrations of Azithromycin during and after End of Therapy
2013
Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients
1997